Brief: Altamira Therapeutics, Pharma Nordic Collaborate For Marketing And Distribution Of Bentrio In Scandinavia
20/07/2023 14:22
July 20 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS AND PHARMA NORDIC COLLABORATE FOR
MARKETING AND DISTRIBUTION OF BENTRIO IN SCANDINAVIA
* ALTAMIRA THERAPEUTICS LTD - COLLABORATION AGREEMENT WILL
ALLOW
PHARMA NORDIC TO MARKET AND COMMERCIALIZE BENTRIO IN NORWAY
BEGINNING IN Q1 OF 2024
* ALTAMIRA THERAPEUTICS: DEAL TO ALLOW PHARMA NORDIC TO
MARKET
BENTRIO IN SWEDEN, FINLAND, DENMARK AFTER Q1 2024, SUBJECT TO
MEETING CERTAIN MILESTONES
Source text for Eikon: ID:nGNX1J7cx1
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering